Our Stories

Researchers from Quest Diagnostics presented original research on Alzheimer’s disease (AD), based on Quest’s AD-Detect® suite of blood-based biomarker (BBM) testing, at two leading...

Despite widely available lab tests and curative treatment, hepatitis C virus (HCV) remains one of the most common blood-borne infections in the United States. Researchers from Quest Diagnostics,...

In June, researchers from Quest Diagnostics published findings of a national study in The Journal of Clinical Endocrinology and Metabolism (JCEM), the leading clinical journal of the Endocrine...

Experts from Quest Diagnostics will highlight data from 13 studies on a range of laboratory topics at the 2026 Association for Diagnostics & Laboratory Medicine’s (ADLM) Annual Meeting, July 26-30,

Quest Diagnostics presented research results at the American Diabetes Association’s 2026 Scientific Sessions, which occurred in New Orleans on June 5-8. The study, presented as a poster, was...